A new study suggests that moderate consumption of coffee on a regular basis may help prevent cardiometabolic multimorbidity. The research, published in the Endocrine Society’s Journal of Clinical Endocrinology & Metabolismexamined data from the UK Biobank, which is a broader database feature the health information of more than 500,000 people between the ages of 37 and 73.
This new study found that, compared with people who did not drink caffeine at all or who drank less than 100 milligrams (mg) per day, people who drank three coffee drinks per day or 200 to 300 mg of caffeine a day had a 48.1% or 40.7% reduced risk for new-onset cardiometabolic diseases.
Previous studies have assessed the potential benefits of coffee, tea, and caffeine, but their role in the prevention of any cardiometabolic diseases has not been clearly defined.
This study’s results, too, suggest an association rather than a causal relationship. Nevertheless, this association may be meaningful to health, seeing that people with a single cardiometabolic disease may have twice the mortality risk of those without any cardiometabolic diseases, according to the researchers.
Moreover, those with cardiometabolic multimorbidity may also have an up to seven times higher risk of all-cause mortality. The researchers also noted that cardiometabolic multimorbidity may present higher risks of loss of physical function and mental stress than those with single diseases.
Also Read: Scientists find new blood group solving 50-year-old mystery
